Related Experiment Video
Updated: Sep 18, 2025

Experimental Human Pneumococcal Carriage
Published on: February 15, 2013
Knowledge, Attitude, and Practice of Adult Pneumococcal Vaccination in India: A Prospective, Cross-sectional,
Sripriya Sathyanarayanan1, Santosh Taur2
1Medical Advisor, Pfizer Limited, Mumbai, Maharashtra, India.
Background:
The proportion of the elderly population in India is expected to double by the year 2050. Number of deaths because of lower respiratory tract infections (LRI) caused by Streptococcus pneumoniae are substantial in adults aged >70 years. Pneumococcal diseases are vaccine-preventable diseases (VPDs). Vaccination is safe, effective, and economical protection against infections. However, adult vaccination in India is uncommon. One way to increase it would be to educate the adults accompanying their family to vaccination visits, and improve the adult vaccination rates.
Objective:
In this cross-sectional study, we intend to assess the knowledge, attitude, and practice (KAP) of pediatricians to understand the barriers to pneumococcal vaccination in adults in India.
Materials And Methods:
The study was a descriptive, cross-sectional, questionnaire-based survey in which 650 pediatricians were invited to participate. The survey consisted of structured questions sent to the participants in Microsoft Form through emails. The responses were collected, analyzed, and compared for final interpretations using SPSS software.
Results:
Of the total 500 pediatricians who consented to study participation, one-third (39.6%) of pediatricians would recommend pneumococcal vaccination to adults >60 years accompanying the children, and 33.2% of the pediatricians reported that they vaccinate adults only when presented with a prescription or advised by the adult's treating physician. Most pediatricians (72.1%) reported that among their patients they would give the highest priority for pneumococcal vaccination in adolescents with chronic lung and heart diseases, and 70.4% of the pediatricians reported that only about one in five families (5-20%) consulting with them are aware of adult vaccination other than the COVID-19 vaccine. Pediatricians (80%) gave the highest priority to "low awareness regarding pneumococcal disease in adults," while only 30.4% of the pediatricians had taken the pneumococcal vaccination.
Conclusion:
The study objectively identifies barriers to pneumococcal vaccination in adults in India from the pediatrician point of view. There is a lack of awareness among pediatricians about adult vaccination recommendations. National guidelines among pediatricians for adult vaccination, including data on vaccine safety, efficacy, and disease burden, would help pediatricians in counseling adults for vaccination. Per the pediatricians, patient-level barriers to vaccinations are poor awareness and understanding of both adult pneumococcal disease and vaccination, along with affordability.
Related Concept Videos
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pneumonia III: Complications and Assessment
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Vaccinations
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...

